Pantoprazole Uses, Dosage, Side Effects and Interactions
Protonix
Protonix was the first pantoprazole product the FDA approved, in February 2000. An FDA-approved generic with the same active ingredient is listed.
Protonix I.V.
Protonix I.V. is a brand name for pantoprazole. Generic pantoprazole is listed with the FDA.
Protonix Delayed-Release
Protonix Delayed-Release is a brand name for pantoprazole. Generic pantoprazole is listed with the FDA.
Pantoprazole is a proton pump inhibitor (a stomach acid reducer) used to treat and maintain healing of erosive esophagitis from gastroesophageal reflux disease (GERD), and to treat conditions of excess stomach acid such as Zollinger-Ellison syndrome.
Quick links
Ask Anything About PantoprazoleType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Pantoprazole in Short
- Drug class Proton Pump Inhibitor How the FDA classifies it
What it treatsPantoprazole treats problems caused by too much stomach acid. By mouth (delayed-release tablets, and delayed-release oral suspension granules, including Protonix), it is used for short-term treatment of erosive esophagitis (damage to the esophagus lining) associated with GERD.
- How you get it Prescription only
- Comes asDelayed-release tablet, injection and oral powderAvailable strengths
Delayed-release tablet (by mouth)
- 20 mg
- 40 mg
Injection (into a vein)
- 40 mg
- 40 mg/10 mL
- 40 mg/50 mL
- 40 mg/100 mL
See forms and strengths+ 2 more strengthsShow fewer strengths
Injection (into a vein)
- 80 mg/100 mL
Oral powder (by mouth)
- 40 mg
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Pantoprazole sodium (tablet, delayed release); Protonix (tablet, delayed release)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs157 interact 3 major, 103 moderate and 51 minor
- What pharmacies pay
- Generic$0.04 a tablet
- Protonix (brand)$14.20 to $14.31 a tablet
- Injections, generic: $2.37 each
The pharmacy’s own cost, national average. Not your price See every price+ 2 more price detailsShow fewer price details
- Oral powder, generic: $2.85 each
- Oral powder, Protonix: $14.08 each
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Pantoprazole (Protonix) is a proton pump inhibitor that blocks the last step of stomach acid production, a common first choice for healing and then protecting erosive esophagitis (damage to the esophagus lining) from GERD and for excess-acid conditions such as Zollinger-Ellison syndrome; it has been on the U.S. market since about 2000, with FDA-approved generics listed. Most people tolerate it well, and headache or diarrhea are the side effects most often noticed. Watch for diarrhea that does not improve, which can be a gut infection called C. difficile, and stop it and get help right away for a blistering or peeling rash.
Key Takeaways From the HelloPharmacist Team
- Take it once daily (twice for Zollinger-Ellison); tablets are fine with or without food, but granules go about 30 minutes before a meal.
- Healing courses run up to 8 weeks; if you stay on it longer, ask about magnesium and vitamin B-12 checks and bone health.
- If you take warfarin, expect extra INR (clotting) checks, and know it can lower how well iron and some antifungals are absorbed.
- Report feeling generally unwell with nausea and loss of appetite promptly, since that can signal kidney inflammation from this medicine.
Patient Information Guide for Pantoprazole
What It’s Used For
Pantoprazole is a proton pump inhibitor used for acid-related conditions. Uses depend on the product:
- Oral tablets and oral suspension granules (including Protonix): short-term treatment (up to 8 weeks) of erosive esophagitis associated with GERD in adults and children 5 years and older.
- Oral forms (adults): maintenance of healing of erosive esophagitis and reduction in relapse of daytime and nighttime heartburn in GERD.
- Oral forms: long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
- Pantoprazole sodium for injection (intravenous): GERD with a history of erosive esophagitis for up to 10 days in adults, and pathological hypersecretory conditions including Zollinger-Ellison syndrome in adults. One injection product is labeled for 7 to 10 days.
- Protonix I.V.: also labeled for children 3 months and older for up to 7 days.
- Injection products are not established for upper gastrointestinal bleeding.
How It Works
Pantoprazole blocks the final step of stomach acid production. It binds to the (H+, K+)-ATPase “proton pump” enzyme in the stomach’s acid-producing cells. This lowers both baseline and stimulated acid, with an effect lasting longer than 24 hours.
Drug Class
Drug Class
- Proton Pump Inhibitor
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Proton Pump Inhibitor
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Proton Pump Inhibitors
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Pantoprazole in the FDA’s index.
From our Patient Information GuidePantoprazole blocks the final step of stomach acid production. It binds to the (H+, K+)-ATPase “proton pump” enzyme in the stomach’s acid-producing cells. Read How Pantoprazole Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Pantoprazole in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Proton pump inhibitors
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Pantoprazole is taken by mouth or given into a vein, and the plan depends on your condition and product. Your prescriber sets the dose and length of treatment.
- Oral tablets are taken once daily for erosive esophagitis and can be taken with or without food. Zollinger-Ellison syndrome is usually dosed more often.
- Oral suspension granules are taken about 30 minutes before a meal, for example sprinkled on applesauce or mixed with apple juice.
- Injection is given by a healthcare professional over a few minutes or as a 15-minute infusion, and is switched to an oral medicine as soon as possible.
Follow your prescriber and the product label for dosing and what to do about missed doses.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Pantoprazole Taken by Mouth
Healing of erosive esophagitis from acid reflux (GERD)
Adults Usual dose 40 mg once daily
- 40 mg once daily for up to 8 weeks
Good to know
For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course may be considered
Children 5 years and older weighing 15 kg to less than 40 kg Usual dose 20 mg once daily
- 20 mg once daily for up to 8 weeks
Children 5 years and older weighing 40 kg or more Usual dose 40 mg once daily
- 40 mg once daily for up to 8 weeks
Keeping erosive esophagitis healed
For adults
Usual dose 40 mg once daily
Good to know
Controlled studies did not extend beyond 12 months
Conditions with too much stomach acid, including Zollinger-Ellison syndrome
For adults
Usual dose 40 mg twice a day
Highest dose studied Doses up to 240 mg daily have been administered
Good to know
Adjust to individual patient needs and continue as long as clinically indicated
Pantoprazole Injection
Acid reflux (GERD) with a history of erosive esophagitis
For adults
Usual dose 40 mg once daily
- 40 mg once daily by intravenous injection (over at least 2 minutes) or intravenous infusion (for 15 minutes) for up to 10 days
Good to know
Switch to an appropriate oral medication within 10 days
GERD stands for gastroesophageal reflux disease.
Conditions with too much stomach acid, including Zollinger-Ellison syndrome
For adults
Usual dose 80 mg every 12 hours
- 80 mg every 12 hours by intravenous injection (over at least 2 minutes) or intravenous infusion (for 15 minutes)
Good to know
Dosing frequency adjusted to acid output; for higher needs, 80 mg intravenously every 8 hours
Side Effects
Common side effects in adults include:
Common side effects
- Headache
- Diarrhea
- Nausea
- Abdominal (belly) pain
- Vomiting
- Gas (flatulence)
- Dizziness
- Joint pain
When to get medical help
- Severe skin reactions such as blistering, peeling or widespread rash, or signs of a serious allergic reaction like swelling or trouble breathing: stop the medicine and get medical help right away.
- Signs of kidney inflammation (acute tubulointerstitial nephritis), such as feeling unwell, nausea, loss of appetite or reduced kidney function: tell your doctor promptly.
- Diarrhea that does not improve: it could be a Clostridium difficile infection.
- A new or worsening rash, especially on sun-exposed skin, or joint pain: this could be lupus, so contact your doctor.
- Muscle spasms, irregular heartbeat or seizures: these can be signs of low magnesium.
- Symptoms that return soon after treatment or respond poorly: tell your doctor so other causes, including stomach cancer, can be checked.
In children, upper respiratory infection, fever and rash were also common. Seek help for severe skin reactions, allergic reactions, diarrhea that does not improve, signs of kidney problems, new rash or joint pain, or muscle spasms and irregular heartbeat.
Warnings and Precautions
- Stomach cancer is not ruled out by symptom relief in adults. Poor response or early return of symptoms may call for more testing.
- Kidney inflammation (acute tubulointerstitial nephritis) can occur at any point during treatment.
- C. difficile diarrhea risk may be higher with PPIs, especially in hospitalized patients.
- Bone fractures of the hip, wrist or spine are linked with high-dose or year-plus use.
- Severe skin reactions and lupus have been reported. The medicine should be stopped if they occur.
- Low vitamin B-12 or magnesium can occur with long-term use.
- Fundic gland polyps risk rises with use beyond one year.
- In long-term rodent studies, pantoprazole caused tumors. The relevance to humans is unknown.
Interactions
Pantoprazole can affect, or be affected by, several medicines:
- Rilpivirine products: must not be combined.
- Nelfinavir, atazanavir, saquinavir: may lower or raise levels of these HIV drugs.
- Warfarin: can raise INR and bleeding risk.
- High-dose methotrexate: levels may rise and last longer.
- Drugs needing stomach acid (iron salts, erlotinib, dasatinib, nilotinib, ketoconazole, itraconazole): absorption can drop.
- Mycophenolate mofetil: exposure to its active form may drop.
- Clopidogrel: no dose adjustment needed.
- Lab tests: can cause false-positive urine THC and neuroendocrine tumor tests.
Interactions Listed in the FDA-Approved Label
From the Pantoprazole prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Rilpivirine-containing productsWhat happensDecreased exposure may reduce antiviral effect and promote drug resistance.What to doConcomitant use is contraindicated.
-
What happensDecreased exposure may reduce antiviral effect and promote drug resistance.What to doSee prescribing information for atazanavir for dosing information.
-
What happensDecreased exposure may reduce antiviral effect and promote drug resistance.What to doAvoid concomitant use.
-
SaquinavirWhat happensIncreased exposure may increase toxicity of saquinavir.What to doMonitor for potential saquinavir toxicities.
-
What happensIncreased INR and prothrombin time, which may lead to abnormal bleeding and even death.What to doMonitor INR and prothrombin time; warfarin dose adjustment may be needed.
-
What happensNo clinically important effect on exposure to clopidogrel's active metabolite or platelet inhibition.What to doNo dose adjustment of clopidogrel is necessary.
-
What happensMay elevate and prolong serum levels of methotrexate and/or hydroxymethotrexate, possibly leading to toxicity.What to doA temporary withdrawal of pantoprazole may be considered in some patients on high-dose methotrexate.
-
Mycophenolate mofetilWhat happensReduces exposure to the active metabolite mycophenolic acid; clinical relevance on organ rejection not established.What to doUse with caution in transplant patients receiving MMF.
-
Drugs dependent on gastric pH for absorption For example: iron salts, erlotinib, dasatinib, nilotinib, ketoconazole/itraconazoleWhat happensPantoprazole can reduce their absorption by reducing intragastric acidity.What to doSee the prescribing information for those drugs.
-
Neuroendocrine tumor investigations (CgA tests)What happensCgA levels increase, which may cause false positive results.What to doTemporarily stop pantoprazole at least 14 days before assessing CgA levels; use the same laboratory for serial tests.
Read the label’s full interactions text
7 DRUG INTERACTIONS Table 4 includes drugs with clinically important drug interactions and interaction with diagnostics when administered concomitantly with pantoprazole sodium for delayed-release oral suspension and instructions for preventing or managing them. Consult the labeling of concomitantly used drugs to obtain further information about interactions with PPIs. Table 4: Clinically Relevant Interactions Affecting Drugs Co-Administered with Pantoprazole Sodium for Delayed-Release Oral Suspension and Interactions with Diagnostics Antiretrovirals Clinical Impact: The effect of PPIs on antiretroviral drugs is variable. The clinical importance and the mechanisms behind these interactions are not always known. Decreased exposure of some antiretroviral drugs (e.g., rilpivirine, atazanavir, and nelfinavir) when used concomitantly with pantoprazole may reduce antiviral effect and promote the development of drug resistance. Increased exposure of other antiretroviral drugs (e.g., saquinavir) when used concomitantly with pantoprazole may increase toxicity of the antiretroviral drugs. There are other antiretroviral drugs which do not result in clinically relevant interactions with pantoprazole. Intervention: Rilpivirine-containing products: Concomitant use with pantoprazole sodium for delayed-release oral suspension is contraindicated. See prescribing information. Atazanavir: See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with pantoprazole sodium for delayed-release oral suspension. See prescribing information for nelfinavir. Saquinavir: See the prescribing information for saquinavir and monitor for potential saquinavir toxicities. Other antiretrovirals: See prescribing information. Warfarin Clinical Impact: Increased INR and prothrombin time in patients receiving PPIs, including pantoprazole, and warfarin concomitantly.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if allergic to pantoprazole or similar medicines (substituted benzimidazoles), or if taking rilpivirine.
- Tell your prescriber if you are pregnant, planning pregnancy or breastfeeding.
- Oral use for erosive esophagitis is labeled for children 5 years and older. Safety beyond 8 weeks in children is not established.
- Older adults with a poor response may need further evaluation.
- Mention low magnesium or calcium, osteoporosis risk, lupus, or use of digoxin or diuretics.
Overdose
Experience with very high doses (above 240 mg) is limited, and reports have generally fit the known safety profile. Pantoprazole is not removed by hemodialysis, so treatment is symptomatic and supportive. If you think too much was taken, call Poison Control at 1-800-222-1222.
Half-Life and How Your Body Processes It
Delayed-release tablets are enteric-coated, so absorption begins only after they leave the stomach, with peak levels in about 2.5 hours. Food may delay absorption but does not change the amount absorbed from tablets. Pantoprazole is broken down in the liver (mainly CYP2C19 and CYP3A4) and has a half-life of about one hour. Most of it leaves in the urine as metabolites, with the rest in the feces.
Storage
Store PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Pantoprazole
From the licensed clinical database we use, rolled up per supplement, most serious first.157 supplements and herbal products have documented interactions with Pantoprazole in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 3Major
- 103Moderate
- 51Minor
- ACTIVATED CHARCOALMajor
- GRAPEFRUITMajor
- ST. JOHN'S WORTMajor
- 7,8-BENZOFLAVONEModerate
- ACACIA RIGIDULAModerate
- ADRAFINILModerate
- AFRICAN WILD POTATOModerate
- AMERICAN ELDERModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrients Pantoprazole May Deplete
Nutrients Pantoprazole has been linked with lower levels of, from the licensed clinical database we use.Pantoprazole has been associated with lower levels of 9 nutrients in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Evidence and significance: 1 higher significance, 1 moderate, 4 lower / possible, 3 unrated
- Magnesium Major Depletion
- Vitamin B12 Moderate Depletion
- Calcium Insignificant Depletion
- Folic Acid Insignificant Depletion
- Iron Insignificant Depletion
- Zinc Insignificant Depletion
- Beta-Carotene Insufficient Evidence
- Chromium Insufficient Evidence
Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.
Pantoprazole: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Pantoprazole — the kind of thing our pharmacy team would talk through with you at the counter.
What is pantoprazole used for?
How should I take pantoprazole?
What side effects should I expect?
Can I take pantoprazole with other medicines?
Is pantoprazole safe during pregnancy or breastfeeding?
Is it okay to use pantoprazole for a long time?
Is pantoprazole available over the counter?
When was pantoprazole first available?
Who makes pantoprazole?
What is the brand name of pantoprazole?
What is the generic name of Protonix?
What drug class is pantoprazole?
Is there a generic version of pantoprazole?
What strengths does pantoprazole come in?
How much does pantoprazole cost?
Is there a pantoprazole shortage?
Where can I read the pantoprazole prescribing information (package insert)?
Can you crush pantoprazole?
Is pantoprazole gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Pantoprazole
Skip the scrolling. Ask in your own words and get an answer from Pantoprazole’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Pantoprazole’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Pantoprazole on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Pantoprazole Forms and Strengths (How It Comes)
Pantoprazole comes in 3 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Pantoprazole inactive ingredients by manufacturer.
Delayed-release tablet
How this form is used
- Protonix delayed-release tablets are used for short-term treatment of erosive esophagitis associated with GERD.
- Protonix delayed-release tablets are used to maintain healing of erosive esophagitis in adults.
- Protonix delayed-release tablets are used for long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
- Pantoprazole sodium delayed-release tablets are enteric-coated and may be taken without regard to timing of meals.
Injection
How this form is used
- Pantoprazole sodium for injection is used in adults for GERD with a history of erosive esophagitis for up to 10 days.
- Pantoprazole sodium for injection is used in adults for pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
- Protonix I.V. is also labeled for children 3 months and older with GERD and a history of erosive esophagitis for up to 7 days.
- Pantoprazole sodium for injection has not been shown safe and effective for upper gastrointestinal bleeding.
- Pantoprazole sodium for injection is given into a vein, as a short injection or a 15-minute infusion.
- Pantoprazole sodium for injection should be stopped as soon as you can take an oral treatment.
Oral powder
How this form is used
- Protonix delayed-release granules for oral suspension are used for short-term treatment of erosive esophagitis associated with GERD.
- Protonix delayed-release granules for oral suspension are used for maintenance of healing of erosive esophagitis in adults.
- Protonix delayed-release granules for oral suspension are used for pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
- Pantoprazole sodium delayed-release granules should be taken about 30 minutes before a meal.
- Pantoprazole sodium delayed-release granules can be taken sprinkled on a teaspoonful of applesauce or mixed with apple juice.
Pantoprazole on the U.S. Market: Products, Makers and Brands
How Pantoprazole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
68 companies list 168 Pantoprazole product records with the FDA, mostly as delayed-release tablet, injection, oral powder; the earliest marketing or approval year on record is 2000. Brand names in the directory today include Protonix, Protonix I.V. and Protonix Delayed-Release; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (28) · Unfinished tablet, delayed release (6) · Unfinished injection, powder, for solution (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Pantoprazole Is Used (Medicaid Data)
How many Pantoprazole prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Pantoprazole prescribed? Of the 1,682 medications we measure, Pantoprazole ranks #32 by Medicaid prescriptions — more than 98% of them.
Utilization by Pantoprazole product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
pantoprazole 40 MG Delayed Release Oral Tablet Most dispensed
30 of 265 listed NDCs had Medicaid claims. RxNorm 314200
pantoprazole 20 MG Delayed Release Oral Tablet
16 of 242 listed NDCs had Medicaid claims. RxNorm 251872
pantoprazole 40 MG Injection
21 of 71 listed NDCs had Medicaid claims. RxNorm 283669
pantoprazole 40 MG Oral Granules
9 of 18 listed NDCs had Medicaid claims. RxNorm 763306
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 76 of the 596 listed Pantoprazole NDCs had Medicaid claims.
Compare Pantoprazole Products
A representative set of FDA-listed product records for Pantoprazole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Delayed-release tablet | ||||
| 20 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 20 mg | Oral | Advanced Rx of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 20 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 40 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 20 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 40 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 20 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 40 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Asclemed USA, Inc. × 3 listings | ANDA | View NDC → |
| 40 mg | Oral | Asclemed USA, Inc. × 3 listings | ANDA | View NDC → |
| 20 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 40 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 20 mg | Oral | AvPAK | ANDA | View NDC → |
| 40 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 40 mg | Oral | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 40 mg | Oral | Burel Pharmaceuticals, LLC | ANDA | View NDC → |
| 20 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Cardinal Health 107, LLC × 4 listings | ANDA | View NDC → |
| 20 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 40 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 20 mg | Oral | Coupler LLC × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 20 mg | Oral | Direct Rx | ANDA | View NDC → |
| 40 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 20 mg | Oral | Dr.Reddy's Laboratories Limited | ANDA | View NDC → |
| 40 mg | Oral | Dr.Reddy's Laboratories Limited | ANDA | View NDC → |
| 20 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Granules Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg | Oral | Granules Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | Hawaii Repack, Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Hawaii Repack, Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Jubilant Cadista Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 40 mg | Oral | Major Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Mylan Institutional Inc. | ANDA | View NDC → |
| 20 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 40 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 20 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 40 mg | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 40 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 20 mg | Oral | Northwind Health Company, LLC × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 20 mg | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 20 mg | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 40 mg | Oral | NuCare Pharmaceuticals,Inc. × 6 listings | ANDA | View NDC → |
| 40 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Phoenix Rx Llc × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 40 mg | Oral | QPharma Inc × 3 listings | ANDA | View NDC → |
| 20 mg | Oral | Quality Care Products, LLC | ANDA | View NDC → |
| 20 mg | Oral | Quallent Pharmaceuticals Health LLC | ANDA | View NDC → |
| 40 mg | Oral | Quallent Pharmaceuticals Health LLC | ANDA | View NDC → |
| 40 mg | Oral | Redpharm Drug × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 40 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Safecor Health LLC | ANDA | View NDC → |
| 20 mg | Oral | Sportpharm LLC | ANDA | View NDC → |
| 40 mg | Oral | Sportpharm LLC | ANDA | View NDC → |
| 20 mg | Oral | St. Mary's Medical Park Pharmacy | ANDA | View NDC → |
| 40 mg | Oral | St. Mary's Medical Park Pharmacy | ANDA | View NDC → |
| 20 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 40 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 20 mg | Oral | Unit Dose Solutions, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Unit Dose Solutions, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| 40 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| 20 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 💊Injection | ||||
| 40 mg/10 mL | Intravenous | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Avenacy, LLC | ANDA | View NDC → |
| 40 mg/50 mL | Intravenous | Baxter Healthcare Company | NDA | View NDC → |
| 40 mg/100 mL | Intravenous | Baxter Healthcare Company | NDA | View NDC → |
| 80 mg/100 mL | Intravenous | Baxter Healthcare Company | NDA | View NDC → |
| 40 mg/10 mL | Intravenous | BE Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 40 mg | Intravenous | Cardinal Health 107, LLC | ANDA | View NDC → |
| 40 mg | Intravenous | Cardinal Health 107, LLC | NDA | View NDC → |
| 40 mg/10 mL | Intravenous | Cardinal Health 107, LLC × 2 listings | NDA | View NDC → |
| 40 mg | Intravenous | Civica, Inc. | NDA | View NDC → |
| 40 mg/10 mL | Intravenous | Devatis Inc. | ANDA | View NDC → |
| 40 mg | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 40 mg | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | NDA | View NDC → |
| 40 mg/10 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Northstar Rx LLC | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Piramal Critical Care | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Sandoz Inc | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Sun Pharmaceutical Industries Limited | ANDA | View NDC → |
| 40 mg/10 mL | Intravenous | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. × 2 listings | NDA | View NDC → |
| 💊Oral powder | ||||
| 40 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 40 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Edenbridge Pharmaceuticals LLC. | ANDA | View NDC → |
| 40 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 40 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| 💊Oral suspension | ||||
| 40 mg | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 40 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 40 mg | Oral | Cipla USA Inc. | ANDA | View NDC → |
| 💊Tablet | ||||
| 20 mg | Oral | Lifestar Pharma LLC | ANDA | View NDC → |
| 40 mg | Oral | Lifestar Pharma LLC | ANDA | View NDC → |
Showing 168 of 168 products — FDA National Drug Code Directory. See every product, package size and price: browse all 168 Pantoprazole NDCs →
Pantoprazole Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Pantoprazole — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Pantoprazole are chronic kidney disease, fatigue, nausea; about 81% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Pantoprazole in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Pantoprazole FDA Approval History
How Pantoprazole went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Pantoprazole was first approved by the FDA in 2000 (Brand: PROTONIX · Wyeth Pharms); the first generic version was approved in 2007. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Pantoprazole Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 6 Pantoprazole recalls since July 2021. Three of them are still ongoing or began in the last six months and are listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60… Lots: Lot # NC194129, Exp Date: 05/07/2028. FDA record D-0812-2026 →
- Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Po… Lots: Batch # FD253967, Exp Date: 06/26/2027 FDA record D-0484-2026 →
- Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Ja… Lots: Lot #: PAN22542, Exp. Date: 9/2024 FDA record D-0530-2023 →
- Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. i… Lots: Lots: (a) GSC04002A, GSC04003A, GSC04004A, GSC04006A, Exp Mar-2024; GSC05001A, GSC05006A, GSC05007A, Exp April-2024; GSC10003A, GSC10005A Exp Sep-2024;GSC06004A, GSC06005A, Exp May-2024; GSC07001A, GSC07007A, GSC07008A, GSC07009A, Exp Jun-… FDA record D-1148-2023 →
- Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet contains 40 mg pantoprazole equivalent to 45.1 mg of pantoprazole sodium USP (s… Lots: Lot #: MHC1317A, Exp 07/2023 FDA record D-0068-2023 →
- Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., L… Lots: Lot #s: BA34G021, BA34G022, Exp. 09/2022 FDA record D-0852-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Pantoprazole in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 3
- Strengths
- 7
- Forms in current FDA listings
- 3 of 3
RxCUI 40790 -
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1737587Its 4 strengths (SCD)-
40 mg
RxCUI 283669 -
50 mL pantoprazole 0.8 mg/mL
RxCUI 2675784 -
100 mL pantoprazole 0.4 mg/mL
RxCUI 2675781 -
100 mL pantoprazole 0.8 mg/mL
RxCUI 2675786
-
40 mg
-
Dose form (SCDF) Oral GranulesIn current FDA listings
RxCUI 763305Its strength (SCD)-
40 mg
RxCUI 763306
-
40 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Pantoprazole Supply and Shortage Status
Whether Pantoprazole is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Pantoprazole Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Pantoprazole: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.
For the generic 40 mg injection, pharmacies paid an average of $2.37 each as of Nov 18, 2026, up 28% from $1.85 a year earlier.
- What pharmacies pay now
- $2.37
- each, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $2.37 on Oct 21, 2026
- Last 12 months
- Up 28%
- from $1.85 on Nov 19, 2025
- Lowest and highest since Apr 2024
- $1.85 to $3.00
- each
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $2.37 |
| Oct 2026 | $2.37 |
| Sep 2026 | $2.37 |
| Aug 2026 | $2.37 |
| Jul 2026 | $2.37 |
| Jun 2026 | $2.37 |
| May 2026 | $2.37 |
| Apr 2026 | $2.37 |
| Mar 2026 | $2.37 |
| Feb 2026 | $2.37 |
| Jan 2026 | $2.37 |
| Dec 2025 | $1.85 |
| Nov 2025 | $1.85 |
| Oct 2025 | $1.85 |
| Sep 2025 | $1.85 |
| Aug 2025 | $1.85 |
| Jul 2025 | $1.85 |
| Jun 2025 | $1.85 |
| May 2025 | $1.85 |
| Apr 2025 | $1.95 |
| Mar 2025 | $1.99 |
| Feb 2025 | $2.06 |
| Jan 2025 | $2.19 |
| Dec 2024 | $2.34 |
| Nov 2024 | $2.43 |
| Oct 2024 | $2.53 |
| Sep 2024 | $2.53 |
| Aug 2024 | $2.62 |
| Jul 2024 | $2.97 |
| Jun 2024 | $3.00 |
| May 2024 | $2.85 |
| Apr 2024 | $2.72 |
See all 10 prices in a table
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Injection · Intravenous | 40 mg | Generic | $2.37 each | NDC details & price history |
| Injection · Intravenous | 40 mg/10 mL | Generic | $2.37 each | NDC details & price history |
| Delayed-release tablet · Oral | 20 mg | Generic | $0.043 per tablet | NDC details & price history |
| Delayed-release tablet · Oral | 20 mg | Protonix (brand) | $14.31 per tablet | NDC details & price history |
| Delayed-release tablet · Oral | 40 mg | Generic | $0.038 per tablet | NDC details & price history |
| Delayed-release tablet · Oral | 40 mg | Protonix (brand) | $14.20 per tablet | NDC details & price history |
| Oral powder · Oral | 40 mg | Generic | $2.85 each | NDC details & price history |
| Oral powder · Oral | 40 mg | Protonix (brand) | $14.08 each | NDC details & price history |
| Oral powder · Oral | 40 mg | Generic | $2.85 each | NDC details & price history |
| Delayed-release tablet · Oral | 40 mg | Generic | $0.038 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Pantoprazole Brand Names
Pantoprazole has 3 brand names on record: Protonix, Protonix I.V. and Protonix Delayed-Release. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Pantoprazole: Manufacturers and Labelers
68 companies list Pantoprazole products with the FDA. By number of product records, the largest are Cardinal Health 107, LLC, NuCare Pharmaceuticals,Inc., Bryant Ranch Prepack. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 44 more on the FDA NDC directory.
Sources for This Pantoprazole Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →